Publicacións en colaboración con investigadores/as de Fundación Jiménez Díaz (11)

2022

  1. Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group

    Archivos de Bronconeumologia, Vol. 58, Núm. 11, pp. 776-779

  2. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21

2021

  1. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

    Chest, Vol. 160, Núm. 2, pp. 481-490

2020

  1. Long-term Noninvasive Ventilation in Obesity Hypoventilation Syndrome Without Severe OSA: The Pickwick Randomized Controlled Trial

    Chest, Vol. 158, Núm. 3, pp. 1176-1186

2019

  1. Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial

    The Lancet, Vol. 393, Núm. 10182, pp. 1721-1732

2018

  1. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285

2017

  1. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD

    The European respiratory journal, Vol. 50, Núm. 5

2016

  1. Mid- and Long-Term Efficacy of Non-Invasive Ventilation in Obesity Hypoventilation Syndrome: The Pickwick's Study

    Archivos de Bronconeumologia, Vol. 52, Núm. 3, pp. 158-165

  2. Non-invasive ventilation in obesity hypoventilation syndrome without severe obstructive sleep apnoea

    Thorax, Vol. 71, Núm. 10, pp. 899-906

  3. The effect of supplemental oxygen in obesity hypoventilation syndrome

    Journal of Clinical Sleep Medicine, Vol. 12, Núm. 10, pp. 1379-1388

2015

  1. Differential effect of modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD

    Chest, Vol. 148, Núm. 1, pp. 159-168